Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jasminum fruticans methanol extract is a botanical preparation derived from the wild jasmine plant, native to the Mediterranean and Turkey. It contains a variety of bioactive phytochemicals, including phenolic compounds and flavonoids. In preclinical studies, the extract has demonstrated antioxidant properties through radical scavenging and anti-inflammatory activity by reducing the production of nitric oxide, tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), and prostaglandin E2 (PGE2). Additionally, it has shown cytotoxic effects against DU145 prostate cancer and A549 lung cancer cell lines, suggesting potential applications in oncology and inflammatory disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jasminum fruticans methanol extract.